In attempting to seek possible explanations of significant heterogeneity, stratifying studies that assessed circulating apelin concentration between CAD patients and controls by continent, endpoint, apelin source, matching status, sample size, obesity and hypertension were conducted, respectively (Table 4). The gene discussed is APLN; the disease is hypertensive disorder.